Target intelligence / Profile preview

Eukaryotic translation initiation factor 3 subunit L pseudogene 2 (EIF3LP2)

Target
EIF3LP2
Molecular classification
Other (pseudogene)
01

Overview

Eukaryotic translation initiation factor 3 subunit L pseudogene 2 (EIF3LP2) is a human pseudogene, meaning it is a genomic DNA sequence related to the functional gene encoding the eukaryotic translation initiation factor 3 subunit L (EIF3L), but it does not produce a functional protein. Pseudogenes like EIF3LP2 generally arise via gene duplication or retrotransposition followed by accumulation of disabling mutations. EIF3LP2 is catalogued in gene databases such as NCBI Gene (ID: 143341) and Ensembl (ENSG00000233837). There is no evidence for EIF3LP2 involvement in disease, biological function, or as a drug target. EIF3LP2 is distinct from EIF3L (the protein-coding gene for a subunit of the eukaryotic translation initiation factor 3 complex that is involved in protein synthesis initiation). The pseudogene EIF3LP2 does not encode a protein and is not part of the active translation machinery in cells. No therapeutic, diagnostic, or biomarker roles have been described for EIF3LP2. This target is a validated pseudogene, not considered a druggable protein or a molecular therapeutic target.

Other names
EIF3EIPP2EIF3S6IPP2eukaryotic translation initiation factor 3, subunit 6 interacting protein pseudogene 2eukaryotic translation initiation factor 3, subunit 6 interacting protein, putative pseudogeneeukaryotic translation initiation factor 3, subunit E interacting protein pseudogene 2EIF3LP2

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 3 subunit L pseudogene 2 (EIF3LP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit L pseudogene 2 (EIF3LP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call